Alkem Laboratories Ltd vs Fermenta Biotech Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 15, 2026

Key Highlights

The Latest Trading Price of Alkem Laboratories Ltd is ₹ 5296 as of 12 Jun 15:30 . The P/E Ratio of Alkem Laboratories Ltd changed from 20.9 on March 2021 to 26.9 on March 2025 . This represents a CAGR of 5.18% over 5 yearsThe P/E Ratio of Fermenta Biotech Ltd changed from 15.9 on March 2021 to 10.4 on March 2025 . This represents a CAGR of -8.14% over 5 years The Market Cap of Alkem Laboratories Ltd changed from ₹ 33145 crore on March 2021 to ₹ 58347 crore on March 2025 . This represents a CAGR of 11.97% over 5 yearsThe Market Cap of Fermenta Biotech Ltd changed from ₹ 736.66 crore on March 2021 to ₹ 805.08 crore on March 2025 . This represents a CAGR of 1.79% over 5 years The revenue of Alkem Laboratories Ltd for the Mar '26 is ₹ 3803 crore as compare to the Dec '25 revenue of ₹ 3879 crore. This represent the decline of -1.97% The revenue of Fermenta Biotech Ltd for the Mar '26 is ₹ 135.72 crore as compare to the Dec '25 revenue of ₹ 140.48 crore. This represent the decline of -3.39% The ebitda of Alkem Laboratories Ltd for the Mar '26 is ₹ 582.49 crore as compare to the Dec '25 ebitda of ₹ 918.31 crore. This represent the decline of -36.57% The ebitda of Fermenta Biotech Ltd for the Mar '26 is ₹ 34.14 crore as compare to the Dec '25 ebitda of ₹ 25.89 crore. This represent the growth of 31.87% The net profit of Alkem Laboratories Ltd changed from ₹ 550.24 crore to ₹ 251.68 crore over 8 quarters. This represents a CAGR of -32.37% The net profit of Fermenta Biotech Ltd changed from ₹ -5.93 crore to ₹ 18.6 crore over 8 quarters. This represents a CAGR of NaN% The Dividend Payout of Alkem Laboratories Ltd changed from 21.28 % on March 2021 to 23.59 % on March 2025 . This represents a CAGR of 2.08% over 5 yearsThe Dividend Payout of Fermenta Biotech Ltd changed from 13.87 % on March 2021 to 10.78 % on March 2025 . This represents a CAGR of -4.92% over 5 years .

About Alkem Laboratories Ltd

Headquartered in Mumbai, India, Alkem Laboratories Limited is a leading Indian pharmaceutical company with global operations.
The Company is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products.
The company produces branded generics, generic drugs, active pharmaceutical ingredients (APIs) and nutraceuticals, which it markets in India and international markets. Alkem Laboratories Limited was incorporated as a private limited company on August 8, 1973 in Patna and subsequently became a deemed public limited company on October 26, 1988.
Pursuant to Company passing a resolution under section 21 of Companies Act, 1956 and upon issuance of a fresh certificate of incorporation consequent on change of name dated August 21, 2001, the name of the Company was changed to 'Alkem Laboratories Limited' with effect from October 26, 1988.

About Fermenta Biotech Ltd

Fermenta Biotech Limited was formerly incorporated as 'Duphar-Interfran Limited' in May, 1951.
The Company name was changed to 'DIL Limited' in September, 2003 and later on, was changed to 'Fermenta Biotech Limited' on October 17, 2019.
The Company is presently engaged in pharmaceuticals, manufacturing and marketing Active Pharmaceutical Ingredients, biotechnology, environmental solutions and renting of properties. Initially, Company manufactured and sold toothpaste, anti-septic lotion and pharmaceutical specialities.
It entered into collaborations with Philips-Duphar, Amsterdam (Solvay Duphar), and the Crookes Laboratories, London.
These collaborators participated in the equity capital of the Company to the extent of 25% each. In 1964, Company entered into a collaboration with Solvay Duphar to manufacture vitamin D3.

FAQs for the comparison of Alkem Laboratories Ltd and Fermenta Biotech Ltd

Which company has a larger market capitalization, Alkem Laboratories Ltd or Fermenta Biotech Ltd?

Market cap of Alkem Laboratories Ltd is 63,322 Cr while Market cap of Fermenta Biotech Ltd is 997 Cr

What are the key factors driving the stock performance of Alkem Laboratories Ltd and Fermenta Biotech Ltd?

The stock performance of Alkem Laboratories Ltd and Fermenta Biotech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Alkem Laboratories Ltd and Fermenta Biotech Ltd?

As of June 15, 2026, the Alkem Laboratories Ltd stock price is INR ₹5296.05. On the other hand, Fermenta Biotech Ltd stock price is INR ₹338.8.

How do dividend payouts of Alkem Laboratories Ltd and Fermenta Biotech Ltd compare?

To compare the dividend payouts of Alkem Laboratories Ltd and Fermenta Biotech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.